Biotech Went to Work as the World Stayed Home

One of the key drivers shaping the industry: new financing structures are emerging as viable options. The traditional angel/VC route is no longer the only option for the substantial capital raises needed for R&D and clinical trials.

Is Substack really worth $650M?

Something is worth what someone is willing to pay for it, and apparently investors are willing to pay $65M for 10% of Substack. This begs the question: how much have they given up along the way to raise that money?

What is the best corporate structure for investing?

Best Corporate Structure for Funding

Selecting the best corporate structure for attracting investors is a very important factor to consider when launching a startup, particularly those in capital-intensive sectors such as biotech, medtech, life sciences, pharma, and similar.

SPAC Wave Stirs IPO Competition

SPACs have been all over the headlines the past year, but they’re not the only alternative to traditional IPOs that are booming. Rod Turner explains the differences between SPACs, direct listings, and Regulation A+ offerings.

The Effects of the JOBS Act on Biotech Startups

The 2015 JOBS Act, including Regulation A+, is driving the biotech industry forward. Biotech companies are getting to their IPOs faster, at higher valuations, and using the money to fund further R&D, and hiring to support it.

The $3 Billion Virtual IPO

The push to video conferencing during the pandemic has changed the world of raising capital forever. This CEO raised over $3 billion in their “virtual IPO”, meeting over 1,000 people, including high-profile fund managers, in one-on-ones and groups, via zoom over a 7-day period.

Reg A+ Offerings Are Having a Moment

CFO reports that 2020 was a breakout year for Reg A+ offerings. Roughly $3 billion has been raised via Reg A+ since it began in 2015. Though this option hasn’t received the media coverage that SPACs have, we expect that to change this year.

Valuing Your Data with GAAP

Valuing Your Data with GAAP

As the economy transitions from the Industrial to the Information Age, generally accepted accounting practices (GAAP) have come under fire from analysts and business owners. The issue is the valuation of Intellectual Property (IP) — those non‐physical assets such as trademarks, copyrights, patents, and proprietary databases that have value for their owners.